Peritoneal Malignant Mesothelioma — Trials

Peritoneal Malignant Mesothelioma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02399371	Pembrolizumab in Treating Patients With Malignant Mesothelioma	completed	Phase 2	65	University of ChicagoOTHER	1	May 8, 2026	clinicaltrials
NCT05449366	Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma(INTERACT MESO)	completed	Phase 1 / Phase 2	7	Erasmus Medical CenterOTHER	1	Sep 2, 2025	clinicaltrials